Early detection of cancer is one of the most significant factors that can improve long-term chances of survival for patients in New Jersey. For this reason, scientific research is continually dedicated to new ways to detect cancer while it remains in its most treatable stage. Breast cancer research has been particularly focused on early detection as it is among the most common conditions in America. In fact, breast cancer accounts for 25 percent of all cancer cases.
While outcomes are often successful during breast cancer treatment, any misdiagnosis that leaves the cancer undetected lowers the rate of survival. Some breast lesions are difficult to identify, and this means that it is more likely that they will develop to the point of severe illness and death. Researchers have developed a computer-assisted system that helps to enhance the detection of breast lesions and indicate whether they are cancerous. The technology has the potential to save lives by reducing the number of breast cancer cases that go undiagnosed or misdiagnosed.
During a mammogram, a diagnostic reporting and data system is used to identify breast tumors. However, some growths are more difficult to spot, especially if they blend into surrounding tissue or have ill-defined borders. This technology can help to make clear which tumors are actually dangerous and highlight growths that may otherwise have been missed.
Even using existing technology, however, doctors may miss a breast cancer growth that could have been identified. The results can be devastating, especially when the cancer grows or metastasizes without treatment. People who have experienced worsened health conditions as a result of a misdiagnosis can consult with a medical malpractice attorney to determine the potential to seek compensation for the damages they have suffered.